Our recently expanded coverage of the market for treatments of retinal disease and conditions now includes a quarterly surveying process. Four times yearly, we collect data from US retina specialists on a range of practice of medicine and practice management issues. We began this survey process in 2008. The data we collect is analyzed and presented in our US Retina Quarterly Updates.
These updates are designed to improve your decision-making process with accurate and timely information on a variety of vital practice of medicine issues, doctors’ evaluations of pharmaceuticals and surgical equipment, and the identification of significant trends in the marketplace for retinal pharmaceuticals and devices.
Our updates include trend analysis based on comparisons with information gathered in previous years. All information is presented in color charts and tables with concise narratives for enhanced clarity and context.
Our US Retina Quarterly Updates are designed to keep you up to date with data gathered four times per year on the practice of retinal medicine, both pharmaceutical and surgical.
We measure and analyze the key metrics of the US retina treatments market including the following key topics:
We also provide a full-year forecast for US retina procedures and a comparison with volumes during the prior year.
The Retina Specialists Survey is a longitudinal analysis of the pharmaceutical and surgical treatment of retinal conditions and the products used in those treatments. The survey has been developed in conjunction with retina specialists and industry manufacturers.
US Retina Quarterly Updates are published each quarter. We have been conducting surveys of ophthalmologists in various subspecialties for twelve years, and our analyses of survey data are used by hundreds of ophthalmological practices and businesses in the ophthalmic industry.
Our Quarterly Surveys of US Retina Specialists are a relatively recent addition to our survey process. Since we began to survey retinal specialists, the data we have gathered and analyzed have refined our understanding of the dynamic markets for retinal treatment products and enhanced our comprehensive reports on the retinal pharmaceutical market and the retinal surgical device market.
Table of Contents